The Targeted Genomics Facilities Core (TGFC) is part of an integrated Facility Core program consisting of hypothesis generating, testing, and translational resources within an Integrated Discovery Pipeline, designed to accelerate and advance innovative ideas from hypothesis to practice. The goal of the TGFC is to provide CTEHR investigators with access to highly sophisticated and tailored genetically engineered mouse and modified human cell model systems, which can be used to test novel hypothesis generated by Center members doing cutting-edge EHS research. In the last few years there have been important advances in the gene targeting approaches for generating genetically engineered cells and transgenic animals, including gene trap, engineered nuclease (ZFN) and TALEN technologies. The TGFC will provide CTEHR investigators with streamlined and cost effective generation of genetically engineered (and validated) model systems for their research. The TGFC has both the technology and the necessary expertise to develop these models for investigators in all the of the CTEHR Thematic Focus Areas, by applying economies of scale to their production and validation, and by leveraging the resources already available within the participating institutions. The TGFC will facilitate timely research advances through the following Specific Aims:
Aim 1. Maintain the skilled personnel, molecular technologies and research infrastructure necessary for the generation of state-of-the-art genetically engineered model systems to support CTEHR research.
Aim 2. Provide members with cost effective, prioritized access to services that support the development and use of genetically engineered model systems (cell lines and transgenic mice) to study interactions between the genome and environmental factors that impact human health and disease.
Aim 3. Educate CTEHR members about the application of state-of-the-art genetic engineering technologies to research on the effects of environmental factors on human health and support the career development and mentoring activities of Center investigators Aim 4. Facilitate the translational research activities on the interactions between the genome and environmental factors that impact human health through interactions with the other CTEHR Facility Cores and Programs. The TGFC will provide access to powerful research technologies that will enable CTEHR members to develop and test innovative hypotheses focusing on genome - environment interactions, and their effect on human health. This Core provides the opportunity to evaluate and validate new concepts in genetically relevant model systems as part of integrated """"""""discovery pipeline"""""""" involving hypothesis generation, testing and translation. Use of this pipeline will accelerate the process of advancing innovative ideas and translating them to improvement of environmental health and mitigation of environmental disease.
Program Narrative - Targeted Genomics Facility Core The Targeted Genomics Facility Core (TGFC) provides an important link in the discovery research program of the CTEHR by providing trainees and investigators with access to sophisticated model systems that are critical to the study of the interactions between the genome and environmental factors that contribute to human health and disease.
|McQueen, Cole M; Schmitt, Emily E; Sarkar, Tapasree R et al. (2018) PER2 regulation of mammary gland development. Development 145:|
|Kim, Eunjoo; Wright, Gus A; Zoh, Roger S et al. (2018) Establishment of a multicomponent dietary bioactive human equivalent dose to delete damaged Lgr5+ stem cells using a mouse colon tumor initiation model. Eur J Cancer Prev :|
|Luo, Yu-Syuan; Furuya, Shinji; Chiu, Weihsueh et al. (2018) Characterization of inter-tissue and inter-strain variability of TCE glutathione conjugation metabolites DCVG, DCVC, and NAcDCVC in the mouse. J Toxicol Environ Health A 81:37-52|
|Jonker, Renate; Deutz, Nicolaas E P; Schols, Annemie M W J et al. (2018) Whole body protein anabolism in COPD patients and healthy older adults is not enhanced by adding either carbohydrates or leucine to a serving of protein. Clin Nutr :|
|Pogribny, Igor P; Dreval, Kostiantyn; Kindrat, Iryna et al. (2018) Epigenetically mediated inhibition of S-adenosylhomocysteine hydrolase and the associated dysregulation of 1-carbon metabolism in nonalcoholic steatohepatitis and hepatocellular carcinoma. FASEB J 32:1591-1601|
|Jonker, Renate; Deutz, Nicolaas E P; Ligthart-Melis, Gerdien C et al. (2018) Preserved anabolic threshold and capacity as estimated by a novel stable tracer approach suggests no anabolic resistance or increased requirements in weight stable COPD patients. Clin Nutr :|
|Deutz, Nicolaas E P; Thaden, John J; Ten Have, Gabriella A M et al. (2018) Metabolic phenotyping using kinetic measurements in young and older healthy adults. Metabolism 78:167-178|
|Lacey, Alexandra; Hedrick, Erik; Cheng, Yating et al. (2018) Interleukin-24 (IL24) Is Suppressed by PAX3-FOXO1 and Is a Novel Therapy for Rhabdomyosarcoma. Mol Cancer Ther 17:2756-2766|
|Fuentes, Natividad R; Kim, Eunjoo; Fan, Yang-Yi et al. (2018) Omega-3 fatty acids, membrane remodeling and cancer prevention. Mol Aspects Med 64:79-91|
|Engelen, Mariëlle P K J; Deutz, Nicolaas E P (2018) Is ?-hydroxy ?-methylbutyrate an effective anabolic agent to improve outcome in older diseased populations? Curr Opin Clin Nutr Metab Care 21:207-213|
Showing the most recent 10 out of 166 publications